A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque

Clinical trial NCT06305559 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06305559
Sponsor: NewAmsterdam Pharma
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lipidemia Coronary Artery Disease Plaque, Atherosclerotic

Start date: 2024-05-16
Primary completion: 2027-11-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.